| Literature DB >> 34421129 |
Gaurab Aditya Dhar1, Shagnik Saha1, Parama Mitra1, Ronita Nag Chaudhuri1.
Abstract
One of the most critical epigenetic signatures present in the genome of higher eukaryotes is the methylation of DNA at the C-5 position of the cytosine ring. Based on the sites of DNA methylation in a locus, it can serve as a repressive or activation mark for gene expression. In a crosstalk with histone modifiers, DNA methylation can consequently either inhibit binding of the transcription machinery or generate a landscape conducive for transcription. During developmental phases, the DNA methylation pattern in the genome undergoes alterations as a result of regulated balance between de novo DNA methylation and demethylation. Resultantly, differentiated cells inherit a unique DNA methylation pattern that fine tunes tissue-specific gene expression. Although apparently a stable epigenetic mark, DNA methylation is actually labile and is a complex reflection of interaction between epigenome, genome and environmental factors prior to birth and during progression of life. Recent findings indicate that levels of DNA methylation in an individual is a dynamic outcome, strongly influenced by the dietary environment during germ cell formation, embryogenesis and post birth exposures. Loss of balances in DNA methylation during developmental stages may result in imprinting disorders, while at any later stage may lead to increased predisposition to various diseases and abnormalities. This review aims to provide an outline of how our epigenome is uniquely guided by our lifetime of experiences beginning in the womb and how understanding it better holds future possibilities of improvised clinical applications. © Archana Sharma Foundation of Calcutta 2021.Entities:
Keywords: DNA methylation; Gene expression; Genomic imprinting; Nutrition
Year: 2021 PMID: 34421129 PMCID: PMC8366481 DOI: 10.1007/s13237-021-00367-y
Source DB: PubMed Journal: Nucleus (Calcutta) ISSN: 0029-568X
Effect of nutrients, dietary supplements, environmental pollutants and lifestyle adaptations on DNA methylation and consequently gene regulation resulting in a plethora of manifestations at different stages of life
| Group | Substance | Age | Phenotype | Molecular effects |
|---|---|---|---|---|
| Methyl group supplements | Betaine or trimethyl glycine | In utero | Affects various features based on regions of hypermethylation—skin pigmentation, tumour suppressor genes, and proto-oncogenes, metabolism specific genes, onset of Type 2 Diabetes mellitus | Global hypermethylation due to SAM generation (15; 83; 88; 89) |
| Vitamins | Vitamin B9 (Folic Acid) | In utero | Affects features based on region of hypermethylation | Global hypermethylation due to SAM metabolite generation [ |
| Adulthood | Decreases the risk of colorectal cancer | Synthesis of Methionine, SAM for the maintenance of DNA methylation (30; 45; 95). | ||
| Ratio of folate and B12 | In utero | B12 deficient and Folate over-supplementation (BDFO) leads to highest mortality rate in mice. Females cannot reproduce | SAM metabolite generation and methylation of CpG islands of DNMT genes affected [ | |
| Vitamin B12 (Cyanocobalamin) | In utero | Affects features based on regions of hypermethylation | Global hypermethylation due to SAM metabolite generation [ | |
| Vitamin C (Ascorbic Acid) | In utero | Females have more primordial germ cells; effect on fertility of the female reproductive system | Co-factor for TET group of enzymes; increases demethylation for germline specific genes to increase their expression during germline reprogramming [ | |
| Lipids | High lipid content in maternal diet | In utero | Increase of leptin in cord blood, increases risk of cancer and type 2 diabetes, cholesterol and insulin levels, neurocognitive functions disrupted | The DNA methylation and other histone modification marks remain as epigenetic memory for several genes predisposing the offspring to risk of these disease phenotypes in adulthood (16; 44; 87) |
| Palmitic acid, oleic acid, arachidonic acid (AHA), docosahexaenoic acid (DHA) in mother's milk | Tendency of obesity in adulthood is lower | Exposure to mother's milk cause a progressive demethylation of Fgf21 and other fatty acid metabolism genes in the offspring liver, reducing the chances of obesity in the offspring [ | ||
| Omega-3-PUFA | Adulthood | Regulation concentration of HDL-C in blood, associated with cardiovascular health | Decreases the methylation of leucocyte ABCA1 gene [ | |
| Plant metabolites | EGCG | Adulthood | Reduces the risk of gastric cancers | Inhibitor of methyltransferases; reactivates genes silenced in cancer (CDX2, BMP2) [ |
| DHCA | Adulthood | Increased peripheral inflammatory cytokine Interleukin 6 is associated with Major Depressive Disorder | Decreases the methylation of introns 1 and 3 of the | |
| Toxic metals | Arsenic, Mercury, Molybdenum, Lead | In utero | Predisposition to cancer and chromosomal anomalies due to DNA damage | Toxic metal exposure affects the global DNA methylation as well as the promoter methylation of DNA damage repair genes, leading to inefficient DNA damage repair [ |
| Environmental pollutants | Diesel exhaust | In utero | Heart related diseases like cardiac hypertrophy, fibrosis and heart failure | Altered methylation of regulatory regions of the DNA leading to aberrant expression of several genes related to heart development [ |
| Bisphenol A from plastic bottles | In utero | Predisposition to neurocognitive disabilities | Exposure leads to an aberrant methylation of | |
| Alcohol | Adulthood | Associated with the susceptibility and adaptation to chronic stress; reduction in GDNF expression affects the behavioural responses to chronic stress | Lack of GDNF expression which leads to dysregulation of endogenously controlled alcoholism [ | |
| Smoking | Adulthood | Associated with immune dysfunction, leading to predisposition to a variety of diseases | Alteration of DNA methylation in genes involved in immune response, haematological pathways, nervous diseases, cancers [ |